vs
Custom Truck One Source, Inc.（CTOS）与Insulet Corporation（PODD）财务数据对比。点击上方公司名可切换其他公司
Insulet Corporation的季度营收约是Custom Truck One Source, Inc.的1.7倍（$783.7M vs $461.6M），Insulet Corporation净利率更高（13.0% vs -0.9%，领先13.9%），Insulet Corporation同比增速更快（31.2% vs -12.6%），过去两年Insulet Corporation的营收复合增速更高（33.2% vs 20.0%）
Custom Truck One Source是北美领先的专用重型卡车及设备解决方案提供商，业务覆盖定制车辆制造、设备销售与租赁、售后配件供应及维保服务，主要服务基建、公用事业、建筑、能源等核心领域。
Insulet Corporation是深耕糖尿病治疗领域的医疗器械企业，核心产品为胰岛素泵，通过持续皮下输注胰岛素的疗法为患者给药。其产品通常由泵主体、一次性胰岛素储药仓，以及包含皮下植入套管和连接管路的一次性输注套件构成，满足不同患者的治疗需求。
CTOS vs PODD — 直观对比
营收规模更大
PODD
是对方的1.7倍
$461.6M
营收增速更快
PODD
高出43.8%
-12.6%
净利率更高
PODD
高出13.9%
-0.9%
两年增速更快
PODD
近两年复合增速
20.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $461.6M | $783.7M |
| 净利润 | $-4.1M | $101.6M |
| 毛利率 | 22.3% | 72.6% |
| 营业利润率 | 6.8% | 18.7% |
| 净利率 | -0.9% | 13.0% |
| 营收同比 | -12.6% | 31.2% |
| 净利润同比 | 76.9% | 0.9% |
| 每股收益（稀释后） | $-0.02 | $1.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTOSPODD
| Q1 26 | $461.6M | — | ||
| Q4 25 | $387.3M | $783.7M | ||
| Q3 25 | $359.9M | $706.3M | ||
| Q2 25 | $392.2M | $649.1M | ||
| Q1 25 | $307.1M | $569.0M | ||
| Q4 24 | $398.3M | $597.5M | ||
| Q3 24 | $337.5M | $543.9M | ||
| Q2 24 | $320.6M | $488.5M |
净利润CTOSPODD
| Q1 26 | $-4.1M | — | ||
| Q4 25 | $20.9M | $101.6M | ||
| Q3 25 | $-5.8M | $87.6M | ||
| Q2 25 | $-28.4M | $22.5M | ||
| Q1 25 | $-17.8M | $35.4M | ||
| Q4 24 | $27.6M | $100.7M | ||
| Q3 24 | $-17.4M | $77.5M | ||
| Q2 24 | $-24.5M | $188.6M |
毛利率CTOSPODD
| Q1 26 | 22.3% | — | ||
| Q4 25 | 31.8% | 72.6% | ||
| Q3 25 | 28.0% | 72.2% | ||
| Q2 25 | 26.1% | 69.7% | ||
| Q1 25 | 27.9% | 71.9% | ||
| Q4 24 | 29.7% | 72.1% | ||
| Q3 24 | 27.2% | 69.3% | ||
| Q2 24 | 27.8% | 67.7% |
营业利润率CTOSPODD
| Q1 26 | 6.8% | — | ||
| Q4 25 | 13.4% | 18.7% | ||
| Q3 25 | 9.1% | 16.7% | ||
| Q2 25 | 7.1% | 18.7% | ||
| Q1 25 | 4.0% | 15.6% | ||
| Q4 24 | 16.9% | 18.3% | ||
| Q3 24 | 6.8% | 16.2% | ||
| Q2 24 | 5.5% | 11.2% |
净利率CTOSPODD
| Q1 26 | -0.9% | — | ||
| Q4 25 | 5.4% | 13.0% | ||
| Q3 25 | -1.6% | 12.4% | ||
| Q2 25 | -7.2% | 3.5% | ||
| Q1 25 | -5.8% | 6.2% | ||
| Q4 24 | 6.9% | 16.9% | ||
| Q3 24 | -5.2% | 14.2% | ||
| Q2 24 | -7.6% | 38.6% |
每股收益（稀释后）CTOSPODD
| Q1 26 | $-0.02 | — | ||
| Q4 25 | $0.10 | $1.42 | ||
| Q3 25 | $-0.03 | $1.24 | ||
| Q2 25 | $-0.13 | $0.32 | ||
| Q1 25 | $-0.08 | $0.50 | ||
| Q4 24 | $0.11 | $1.38 | ||
| Q3 24 | $-0.07 | $1.08 | ||
| Q2 24 | $-0.10 | $2.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.6M | — |
| 总债务越低越好 | $5.1M | $930.8M |
| 股东权益账面价值 | $805.2M | $1.5B |
| 总资产 | $3.5B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.01× | 0.61× |
8季度趋势，按日历期对齐
现金及短期投资CTOSPODD
| Q1 26 | $9.6M | — | ||
| Q4 25 | $6.3M | — | ||
| Q3 25 | $13.1M | — | ||
| Q2 25 | $5.3M | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $3.8M | — | ||
| Q3 24 | $8.4M | — | ||
| Q2 24 | $8.1M | — |
总债务CTOSPODD
| Q1 26 | $5.1M | — | ||
| Q4 25 | $1.6B | $930.8M | ||
| Q3 25 | $1.6B | $934.9M | ||
| Q2 25 | $1.6B | $939.0M | ||
| Q1 25 | $1.6B | $1.6B | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.5B | $1.4B |
股东权益CTOSPODD
| Q1 26 | $805.2M | — | ||
| Q4 25 | $809.1M | $1.5B | ||
| Q3 25 | $784.7M | $1.4B | ||
| Q2 25 | $790.1M | $1.5B | ||
| Q1 25 | $813.4M | $1.3B | ||
| Q4 24 | $861.3M | $1.2B | ||
| Q3 24 | $837.5M | $1.1B | ||
| Q2 24 | $856.7M | $998.4M |
总资产CTOSPODD
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.4B | $3.2B | ||
| Q3 25 | $3.5B | $3.0B | ||
| Q2 25 | $3.6B | $3.5B | ||
| Q1 25 | $3.5B | $3.5B | ||
| Q4 24 | $3.5B | $3.1B | ||
| Q3 24 | $3.6B | $3.0B | ||
| Q2 24 | $3.5B | $2.9B |
负债/权益比CTOSPODD
| Q1 26 | 0.01× | — | ||
| Q4 25 | 2.03× | 0.61× | ||
| Q3 25 | 2.10× | 0.68× | ||
| Q2 25 | 2.04× | 0.64× | ||
| Q1 25 | 1.97× | 1.21× | ||
| Q4 24 | 1.77× | 1.07× | ||
| Q3 24 | 1.87× | 1.21× | ||
| Q2 24 | 1.79× | 1.36× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $183.3M |
| 自由现金流经营现金流 - 资本支出 | — | $48.2M |
| 自由现金流率自由现金流/营收 | — | 6.2% |
| 资本支出强度资本支出/营收 | — | 17.2% |
| 现金转化率经营现金流/净利润 | — | 1.80× |
| 过去12个月自由现金流最近4个季度 | — | $377.7M |
8季度趋势，按日历期对齐
经营现金流CTOSPODD
| Q1 26 | — | — | ||
| Q4 25 | $47.3M | $183.3M | ||
| Q3 25 | $81.5M | $125.7M | ||
| Q2 25 | $125.7M | $196.5M | ||
| Q1 25 | $55.6M | $63.8M | ||
| Q4 24 | $82.1M | $147.7M | ||
| Q3 24 | $16.5M | $98.5M | ||
| Q2 24 | $37.8M | $96.5M |
自由现金流CTOSPODD
| Q1 26 | — | — | ||
| Q4 25 | — | $48.2M | ||
| Q3 25 | — | $100.1M | ||
| Q2 25 | — | $177.9M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $94.1M | ||
| Q3 24 | — | $71.8M | ||
| Q2 24 | — | $74.0M |
自由现金流率CTOSPODD
| Q1 26 | — | — | ||
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 14.2% | ||
| Q2 25 | — | 27.4% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | — | 15.7% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 15.1% |
资本支出强度CTOSPODD
| Q1 26 | — | — | ||
| Q4 25 | — | 17.2% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 9.0% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | 4.6% |
现金转化率CTOSPODD
| Q1 26 | — | — | ||
| Q4 25 | 2.27× | 1.80× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 8.73× | ||
| Q1 25 | — | 1.80× | ||
| Q4 24 | 2.98× | 1.47× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | 0.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTOS
| Equipment sales | $292.6M | 63% |
| Rental revenue | $137.2M | 30% |
| Parts sales and services | $31.8M | 7% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
